Akebia Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 19.99 M | $22.78 M | 6.92% | 7.41% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 11.32 M | $12.91 M | 1.39% | 4.20% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 9.15 M | $10.43 M | 410.51% | 3.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 6.73 M | $7.67 M | 4.26% | 2.50% |
| STATE STREET CORP | 09/22/2026 | 5.39 M | $6.15 M | -53.58% | 2.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 4.27 M | $4.87 M | 894.49% | 1.58% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 4.00 M | $4.56 M | 190.83% | 1.49% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 3.69 M | $4.21 M | 2.40% | 1.37% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 3.20 M | $3.64 M | 34.05% | 1.19% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.53 M | $2.89 M | 14.38% | 0.94% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 2.44 M | $2.78 M | 87.75% | 0.90% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 2.30 M | $2.62 M | 14.13% | 0.85% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 2.30 M | $2.62 M | 100.00% | 0.85% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.16 M | $2.46 M | 11.04% | 0.80% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 2.00 M | $2.28 M | 0.00% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.91 M | $2.18 M | 7.28% | 0.71% |
| FMR LLC | 08/13/2026 | 1.87 M | $2.13 M | 40.12% | 0.69% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 1.78 M | $2.03 M | -25.70% | 0.66% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.72 M | $1.96 M | 23.57% | 0.64% |
| UBS GROUP AG | 08/13/2026 | 1.37 M | $1.57 M | 78.69% | 0.51% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.22 M | $1.40 M | -33.23% | 0.45% |
| CITIGROUP INC | 08/03/2026 | 1.12 M | $1.28 M | -60.60% | 0.42% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 839.73 K | $957.29 K | 32.61% | 0.31% |
| MORGAN STANLEY | 08/13/2026 | 701.54 K | $799.76 K | 20.68% | 0.26% |
| INVESCO LTD. | 08/14/2026 | 694.93 K | $792.22 K | -3.50% | 0.26% |
| MANGROVE PARTNERS | 08/14/2026 | 666.95 K | $760.33 K | 77.40% | 0.25% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 626.16 K | $713.82 K | 5,925.98% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 619.15 K | $705.83 K | -4.87% | 0.23% |
| NUVEEN, LLC | 08/11/2026 | 596.60 K | $680.12 K | 0.00% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 589.82 K | $672.40 K | -18.32% | 0.22% |
| CHOREO, LLC | 08/04/2026 | 562.42 K | $641.16 K | 100.00% | 0.21% |
| QUANTINNO CAPITAL MANAGEMENT LP | 08/13/2026 | 562.12 K | $640.82 K | 100.00% | 0.21% |
| CREATIVE PLANNING | 08/13/2026 | 545.74 K | $622.14 K | 209.09% | 0.20% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 531.81 K | $606.27 K | -11.56% | 0.20% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 466.52 K | $531.83 K | 97.58% | 0.17% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 458.75 K | $522.98 K | -83.40% | 0.17% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 427.10 K | $486.89 K | 100.00% | 0.16% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 358.63 K | $408.38 K | -61.10% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 354.91 K | $493.33 K | 48.54% | 0.13% |
| CANADA PENSION PLAN INVESTMENT BOARD | 08/14/2026 | 323.60 K | $368.90 K | 12.56% | 0.12% |
| VIRTUS ETF ADVISERS LLC | 08/11/2026 | 315.74 K | $359.94 K | 2.51% | 0.12% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 308.12 K | $352.00 K | 23.66% | 0.11% |
| RHUMBLINE ADVISERS | 08/12/2026 | 307.50 K | $350.54 K | 0.19% | 0.11% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 300.37 K | $342.42 K | 52.81% | 0.11% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 08/17/2026 | 294.90 K | $336.19 K | 100.00% | 0.11% |
| ALPS ADVISORS INC | 07/29/2026 | 272.26 K | $310.38 K | 24.85% | 0.10% |
| JPMORGAN CHASE & CO | 08/12/2026 | 269.04 K | $298.63 K | 135.90% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 267.30 K | $304.72 K | 43.94% | 0.10% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 256.88 K | $292.85 K | 35.57% | 0.10% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 251.01 K | $286.16 K | 572.94% | 0.09% |
Akebia Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 262 institutional investors and hedge funds held shares of Akebia Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 19.99 M
VANGUARD CAPITAL MANAGEMENT LLC: 11.32 M
AQR CAPITAL MANAGEMENT LLC: 9.15 M
GEODE CAPITAL MANAGEMENT, LLC: 6.73 M
STATE STREET CORP: 5.39 M
JACOBS LEVY EQUITY MANAGEMENT, INC: 4.27 M
40.90% of Akebia Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 149.73 M shares in the last 24 months. This purchase volume represents approximately $202.14 M in transactions.